CIP2A and lung cancer: Here we show that CIP2A is markedly upregulated in lung cancer tumors compared to patient-matched adjacent normal lung tissues, and report that a natural compound which triggers downregulation of CIP2A exhibits significant antitumor activity in NSCLC cell lines.